The Use of Alternative Anti-Coagulation Strategies for a Nocturnal Home Hemodialysis Patient with Heparin-Induced Thrombocytopenia (Clinical Report) More Books Like This

Conversion from Epoetin Alfa to Darbepoetin Alfa Within the Manitoba Renal Program: Evaluation of Dose Ratios.

Impact of Single-Needle Therapy in New Chronic Hemodialysis Starts for Individuals with Arteriovenous Fistulae (Report)

Ontario Formulary

Are CSN and NKF-K/DOQI Mineral Metabolism Guidelines for Hemodialysis Patients Achievable? Results from a Provincial Renal Program (Continuing EDUCATION Series) (Canadian Society of Nephrology) (National Kidney Foundation's Kidney Disease Outcomes Quality Initiative)

Preventing Substitution Errors Involving High-Concentration Heparin Products (ISMP Canada)

Long-Term Soliris Treatment Improves Kidney Function

Drugs - Disprin: Effect Or Side Effect?

Agennix AG Gets Positive Results from Talactoferrin Trial

Cyclacel Reports Phase 2 Survival Data with Sapacitabine

Solnyx Pharmaceuticals: The Atoxeril Clinical Trial

Assistance for Nutrition Improves Rehabilitation - a Follow-up Study of Patients After Colorectal Cancer Surgery/Hjolp Til Ernoring Fremmer Rehabilitering - Et Follow-Up-Studie Af Patienter Opereret for Colorektal Cancer (Report)

-2146826259

Novartis Drug Tasigna Approved in Switzerland After Fast-Track Review for Treatment of Patients with Newly Diagnosed Ph+ CML

A Near Miss Involving Cyclophosphamide (ISMP Canada)

Chelsea Reports Preliminary Phase III Droxidopa Data (Clinical Report)